The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population

Background: Psoriasis is a T-cell mediated chronic inflammatory disorder with multiple skin, nails and joints involvement. The reported prevalence of psoriatic arthritis varies from 5 to 42 cases per 100 psoriasis patients. Insulin resistance is believed to be central to the pathogenesis of metaboli...

Full description

Bibliographic Details
Main Authors: Fatemeh Shirani, Siamak Khaleghi, Mehrdad Nikfam, Ali Pourmojarab
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2016-11-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5505&slc_lang=en&sid=1
id doaj-c623271697064750b6fd2c8a8989528b
record_format Article
spelling doaj-c623271697064750b6fd2c8a8989528b2020-11-24T21:27:48ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222016-11-01748569577The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian populationFatemeh Shirani0Siamak Khaleghi1Mehrdad Nikfam2Ali Pourmojarab3 Department of Rheumatology, Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. Department of Gastroenterology and Hepatology, Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. Department of Internal Medicine, Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. General Practitioner, Researcher, Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran. Background: Psoriasis is a T-cell mediated chronic inflammatory disorder with multiple skin, nails and joints involvement. The reported prevalence of psoriatic arthritis varies from 5 to 42 cases per 100 psoriasis patients. Insulin resistance is believed to be central to the pathogenesis of metabolic syndrome, a constellation of major risk factors for cardiovascular diseases, including atherogenic dyslipidemia, truncal adiposity, hypertension and hyperglycemia. The association of psoriasis and psoriatic arthritis with metabolic syndrome is increasingly being reported. Although the literature relating psoriatic arthritis to metabolic syndrome is accumulating, there is still a paucity of evidence, especially from Asia. Here, we examined the prevalence of metabolic syndrome and its components in patients with psoriatic arthritis. Methods: The study was performed among outpatients attending the specialty clinic and rheumatology ward of Rasoul-e-Akram general hospital between January 2014 and April 2015. A consecutive sample of 80 patients diagnosed as having psoriatic arthritis was studied. Age, gender, body mass index, blood pressure and waist circumference, and history of smoking of patients were measured and asked at the enrolment visit. Venous samples were taken after 8 h of overnight fasting for the estimation of serum lipid profile, glucose and uric acid levels. Also an ultrasonographic examination was done for detection of non-alcoholic fatty liver disease. Results: 46 patients (57.5%) were male and 34 patients (42.5%) were female. Mean age of the participants was 43 years (SD: 11.3). The prevalence of abnormal components of metabolic syndrome was 53.8% for BMI, 48.8% for TG level, 50% for HDL, 46.3 for LDL, 45% for Cholesterol, 23.8% for FBS, 46% for waist circumflex in men and 47.7% in women and 42.5 for uric acid. 40% of the patients had abnormal SBP and 41.2% had abnormal DBP. Thirty percent of the participants were current smokers and 43.8 had NAFLD on ultrasonographic examination. Conclusion: 51.3% of patients had metabolic syndrome according to the adult treatment panel III criteria for adult Asian patients.http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5505&slc_lang=en&sid=1metabolic syndrome psoriasis psoriatic arthritis
collection DOAJ
language fas
format Article
sources DOAJ
author Fatemeh Shirani
Siamak Khaleghi
Mehrdad Nikfam
Ali Pourmojarab
spellingShingle Fatemeh Shirani
Siamak Khaleghi
Mehrdad Nikfam
Ali Pourmojarab
The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population
Tehran University Medical Journal
metabolic syndrome
psoriasis
psoriatic arthritis
author_facet Fatemeh Shirani
Siamak Khaleghi
Mehrdad Nikfam
Ali Pourmojarab
author_sort Fatemeh Shirani
title The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population
title_short The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population
title_full The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population
title_fullStr The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population
title_full_unstemmed The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on Iranian population
title_sort prevalence of metabolic syndrome in psoriatic arthritis patients, a hospital‐based cross-sectional study on iranian population
publisher Tehran University of Medical Sciences
series Tehran University Medical Journal
issn 1683-1764
1735-7322
publishDate 2016-11-01
description Background: Psoriasis is a T-cell mediated chronic inflammatory disorder with multiple skin, nails and joints involvement. The reported prevalence of psoriatic arthritis varies from 5 to 42 cases per 100 psoriasis patients. Insulin resistance is believed to be central to the pathogenesis of metabolic syndrome, a constellation of major risk factors for cardiovascular diseases, including atherogenic dyslipidemia, truncal adiposity, hypertension and hyperglycemia. The association of psoriasis and psoriatic arthritis with metabolic syndrome is increasingly being reported. Although the literature relating psoriatic arthritis to metabolic syndrome is accumulating, there is still a paucity of evidence, especially from Asia. Here, we examined the prevalence of metabolic syndrome and its components in patients with psoriatic arthritis. Methods: The study was performed among outpatients attending the specialty clinic and rheumatology ward of Rasoul-e-Akram general hospital between January 2014 and April 2015. A consecutive sample of 80 patients diagnosed as having psoriatic arthritis was studied. Age, gender, body mass index, blood pressure and waist circumference, and history of smoking of patients were measured and asked at the enrolment visit. Venous samples were taken after 8 h of overnight fasting for the estimation of serum lipid profile, glucose and uric acid levels. Also an ultrasonographic examination was done for detection of non-alcoholic fatty liver disease. Results: 46 patients (57.5%) were male and 34 patients (42.5%) were female. Mean age of the participants was 43 years (SD: 11.3). The prevalence of abnormal components of metabolic syndrome was 53.8% for BMI, 48.8% for TG level, 50% for HDL, 46.3 for LDL, 45% for Cholesterol, 23.8% for FBS, 46% for waist circumflex in men and 47.7% in women and 42.5 for uric acid. 40% of the patients had abnormal SBP and 41.2% had abnormal DBP. Thirty percent of the participants were current smokers and 43.8 had NAFLD on ultrasonographic examination. Conclusion: 51.3% of patients had metabolic syndrome according to the adult treatment panel III criteria for adult Asian patients.
topic metabolic syndrome
psoriasis
psoriatic arthritis
url http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5505&slc_lang=en&sid=1
work_keys_str_mv AT fatemehshirani theprevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT siamakkhaleghi theprevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT mehrdadnikfam theprevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT alipourmojarab theprevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT fatemehshirani prevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT siamakkhaleghi prevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT mehrdadnikfam prevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
AT alipourmojarab prevalenceofmetabolicsyndromeinpsoriaticarthritispatientsahospitalbasedcrosssectionalstudyoniranianpopulation
_version_ 1725973287164444672